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The purified lactose carrier of ~scherichia coli (product of the facY gene) is shown to be a monomer in 
detergent micelles of dodecyl-O&D-maltoside. The negative-dominant phenotype of mutant carriers 
(lacYd mutants) couId not be verified by measurements of the rate of galactoside transport in lacp/ Yd 
diploid strains. It is proposed that the membrane-embedded carrier functions as a monomer in 
galactoside-H+ symport. 
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1. INTRODUCTION 
The lactose: H+ carrier (lactose permease, pro- 
duct of the lacy gene) is an integral protein of the 
cytoplasmic membrane of Escherichiu colt, which 
functions as a galactoside-proton symporter 
[l-3], (review [4]). It has been shown by a com- 
bination of DNA and protein sequencing techni- 
ques [5,6], (K. Beyreuther cited in [4]) as well as by 
gel filtration experiments of the denatured protein 
[7] that the product of the lacy gene is a highly 
hydrophobic protein of M, 46 500 (417 amino acid 
residues). Using overproducing strains [S], the lac- 
tose carrier has been purified and reconstituted in- 
to lipid vesicles [g-12]. The purified and 
reconstituted carrier is fully functional in terms of 
substrate binding, the first step in the translocation 
cycle [ 121. However, under optimized conditions 
the rate constant, &at ractase, for active lactose 
transport in reconstituted vesicles is about IO-times 
smaller (4.3 s-r, [12]) than in cells (50 s-l) but 
similar to that in cytoplasmic membrane vesicles 
(2.9 s-r) derived from E. co& strain ML308-225 
1131. Thus, while all carrier molecules isolated 
recognize substrate, transport rates in pro- 
teoliposome preparations are considerably smaller 
than in cells. The reason for this discrepancy is 
unknown. 
Abbreviations: DodOMalt, dodecyl-O-&D-maltoside; 
Np,&Gal,o-nitrophenyl-&D-galactopyranoside;GalSGal, 
~-D-g~actosyl-l-thio-~-D-g~actopyranoside 
This communication addresses the question of 
whether functional lactose carrier is a monomer or 
oligomer of the A4, 46500 polypeptide chain. The 
possibility of oligomerization has been considered 
in several recent publications. The first argument 
comes from studies on the so-called J& --+ KT- 
shift observed for some permease substrates; e.g., 
lactose (details in [13-191). The experimental 
observation is that the dissociation constant, 
jyytose = 14 mM [13], as well as the half- 
saturation constant for facilitated diffusion (Kp f 
toSe = 24 mM) in the absence of an electrochemical 
proton gradient, A,&+, are about lOO-times larger 
than the half-saturation constant for active 
transport (e = 0.1-0.3 mM) in the presence 
of AFH+ [13,15,16]. To interpret their investiga- 
tions of this effect, Robertson et al. [17] suggested 
that: 
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‘the lac carrier may exist in two forms, 
monomer and dimer, that the monomer 
catalyzes facilitated diffusion and the dimer ac- 
tive transport, and, finally, that AFH+ promotes 
aggregation of monomers to dimers’. 
Secondly, Mieschendahl et al. [20] described a 
class of lacy mutants, designated iacT*, which 
conferred a negative-dominant phenotype in a 
lacY+ background. The negative-dominant 
phenotype might be explained by the formation 
of transport-defective heterodimers or higher 
oligomers from IacT* and lacY+ gene products 
implying that wild-type carrier is likewise func- 
tional as a dimer or higher oligomer. 
Here, we show that the isolated carrier in 
detergent micelles is a monomer and that the 
negative dominance of IacT* mutations is not 
observable by transport measurement in cells. 
2. MATERIALS AND METHODS 
2.1. Determination of M, 
The lactose carrier was purified from the over- 
producing strain T206 [12]. When the amount of 
detergent bound to the carrier was determined, 
DodOMalt [l-14C]Ac (46.4 MBq/mol), prepared 
as in [21], was used throughout the preparation 
and the ECTEOLA-column was equilibrated with 
buffer containing only 0.2 mg DodOMalt/ml. 
Purified carrier (1.3 mg protein/ml) was loaded 
on a 2.5 x 50 cm Sephadex G-100 column 
equilibrated with 10 mM Tris, 20 mg glycerol/ml, 
1 mM NaEDTA, 0.1 mg DodOMalt [l-‘4C]Ac/ml 
(pH 7.5). The carrier-containing micelles were only 
partially resolved from the protein-free micelles. 
The leading fraction contained 87 f 19 mol 
DodOMalt/mol carrier and the average for the 
first three carrier-containing fractions was 121 +- 
17 mol DodOMalt/mol carrier. These values cor- 
respond to 6n = 0.95 and 1.32 g DodOMalt/g car- 
rier. The carrier concentration was determined by 
traces of MalN[3H]Et-labelled carrier which had 
been added to the original vesicle preparation in 
which the carrier content had been determined by 
substrate binding [ 12,131. 
The weight-average M, was determined by 
sedimentation equilibrium in the analytical 
ultracentrifuge as detailed in [22]. The MI is 
calculated from the equilibrium distribution, A280 
profile as a function of the radius (fig.1) by: 
12 
M _ 2RT dd280 1 ---. 
w2 d? 1 -?c@ +6D(l-vDQ) 
(1) 
where: 
(J = the anfular velocity (1571 rad/s); 
vc = the partial specific volume of the carrier 
(0.759 cm3/g, calculated from the amino 
acid composition [5]); 
SD = the amount of detergent bound to the car- 
rier (0.95-l .32 g DodOMalt/g carrier); 
FD = the partial specific volume of the detergent 
(0.81 f 0.01 cm3/g, determined by den- 
sitometry and sedimentation velocity in 
HzO-D20 mixtures); and 
e = the solvent density (1.015 g/cm3). 
The quantity dln&o/d? was determined by the 
best fit (linear correlation coefficient 0.99941) to 
the digitalized data. 
2.2. Transport measurements 
Cells were either grown in Cohen-Rickenberg 
medium [23] in the presence of 0.5% glycerol, 
0.3% casamino acids and thiamin (10 pg/ml) for 
strains K12YMel through MM07 rd4 (cf. table 1) 
or in 1% tryptone, 0.5% yeast extract, 1% NaCl 
for strains HBl and 71-56-10 or this same medium 
plus 20 ,ug ampicillin/ml for strains HB2, HB3, 
and 71-56-10 I’- d3. Cells were induced for 2-3 
generations with 0.5-l x 10m3 M isopropyl-l-thio- 
&D-galactopyranoside. Transport of NpPGal and 
GalSGal and ,&galactosidase activity was deter- 
mined as in [24,25]. 
3. RESULTS 
3.1. Determination of detergent-solubilized 
carrier M,-value 
The lactose carrier is isolated as 
protein-detergent complex [12]. The M, of the 
protein moiety of this complex at sedimentation 
equilibrium can be calculated if the number of 
detergent molecules bound to the carrier and their 
partial specific volume are determined (eq. (l), 
[22]). Gel filtration experiments show that the 
number of DodOMalt molecules/carrier is at least 
87 + 19 and on the average 121 -+ 17. The inability 
to completely separate the carrier-detergent com- 
plex from the pure micelles suggests that both ag- 
gregates have similar Stoke’s radii. The aggrega- 
tion number of DodOMalt under these conditions 
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is about 94. Therefore, these numbers suggest hat 
the purified carrier is located in a micelle. From the 
equilibrium distribution (fig.1) the carrier has M, 
42000 for 0.95 g DodOM~t/g carrier or && 36000 
for 1.32 g DodOMaltlg carrier. Both values are 
close to the value of M, 46500 expected for the 
amino acid sequence [5,6]. Therefore, it is con- 
cluded that the carrier is a monomer in DodOMalt 
micelles . 
3.2. Galactoside transport in lacY+/YWd diploid 
strains 
If an oligomeric structure is necessary for the 
function of the carrier, the replacement of some 
functional subunits by non-functions mutant 
subunits might result in the imp~rment of the ac- 
tivity of the complex. The genetic approach taken 
in [20] led to the isolation of 4 phenotypically 
lacy mutants which were designated Yd because 
they had a trans dominant effect on an unlinked 
lacy allele. The mutations were mapped at 3 dif- 
ferent positions in the lacy gene: Ydl (deletion 
group V), Yd2 (deletion group XXI) and Yd3 and 
Yd4 (both in deletion group XXVIII). Ydl maps 
near the end of the gene corresponding to the N- 
terminus of the carrier while the 3 other mutations 
map in positions correspondi~ to the middle of 
the carrier sequence. It was subsequently shown by 
DNA sequencing that mutations Yd3 and Yd4 are 
identical (Glf62 to ASPIRE; H. Bocklage and B. 
Mtiller-Hill, cited in [4]). The Yd mutations are 
present on an F’facPZM330bYd episome (strains 
HB Ydl and MM05 Yd2 through MM07 Yd4); 
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Fig.1. Distribution of the lactose carrier in DodOMalt 
micdles at sedimentation equilibrium. The data are 
linearized by plotting In A280nm against the square of the 
distance (df from the center of rotation (3). 
Yd3 has also been incorporated into a recombi- 
nant plasmid (strains HB3 and 71-56-10 pYd3). 
The results in table 1 are expressed relative to the 
prototrophic wild-type strain K12YMel. Three 
groups of strains are investigated. The strains in 
the first group (MM04 through MM07 Yd4) all 
carry the promotor mutation pL8 on the 
chromosomal lac operon. Under our conditions, 
this mutation reduces the expression of the adja- 
cent structural genes to l-3% of the wild type as 
judged by the level of&galactosidase. The relevant 
control strain in this group is strain MM03. 
MM03 carries on the episomal lac operon the 
polar mutation Zml’ which completely abolishes 
the expression of the adjacent Y gene. The level of 
Y gene expression in this strain as judged by 
NpflGal transport is thus due to the chromosomal 
r* gene. Replacement of F’lacPZU”8(Y+) in 
strain MM03 by F’lacl+ZM330bY+ (cf. strain 
MM04, the parent of strains HB Yd through 
MM0 Yd4) which allows normal expression of the 
Y gene [24] leads to a 1Pfold increase in transport 
rate. This is a lower estimate since in this strain the 
reduced level of ,&galactosidase may limit the rate 
of NpaCal hydrolysis in vivo. The ratio of the IacY 
gene product derived from the episomal to that of 
the chromosome operon is, therefore, at least 18 
(rate MO04 - rate M0031rate M003). This ratio 
is also expected for the P/Yd heterodiploid 
strains HB Ydl through MM07 Yd4. Com- 
parison of the transport rates of these strains with 
strain MM03 shows that the product of the mu- 
tant Yd genes do not cause a reduction of the 
transport rate of wild-type carrier, derived from 
the chromosomal P gene. Therefore, the 
negative-dominant phenotype of these strains (cf. 
table 1) cannot be confirmed by the determination 
of transport rates. The reason for the discrepancy 
between growth rate and transport rate is not 
known. A likely explanation is that the generation 
time of the P/Y diploid strains is somewhat 
longer than control strains such as strain MM03. 
The negative dominance of mutation Yd3 at the 
level of transport likewise cannot be demonstrated 
in the two other groups of strains (HBl through 
HB3 or 71-56-10 and 71-56-10 pYd3) as shown for 
both Np/3Gal and GalSGal transport. The hybrid 
plasmid carrying the lacTd3 gene does not reduce 
the activity of the Y+ gene located on the F’ factor 
(compare strains HB3 and HBl or 71-56-10 pYd3 
13 
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Table 1 
Transport in phenotypically negative dominant lacy mutants 
Strain lac Genotype Lac NppGal- GalSGal- P-Galacto- 
phenotype transport transport sidase 
Chromosome F’ Plasmid Ws) (Q) (Q) 
K12YMel I+Z’Y+ - + 100 (loo) loo 
MM04 PpL8Z’ Y+ I+zM330b y + 32 n.d. 3 
MM03 PpL8Zi Y+ Pz”lla( Y+) + 1.7 n.d. 1.1 
HBY-*’ lWaz+ Y+ r_zM330bydl - 1.9 n.d. 1.0 
MM05 Y-*’ PPrBZ’ Y+ I+zM330brdZ 2.7 n.d. 1.3 
MM06Yd3 rWaz+ Y+ I+zM33Ob y-d3 3.2 n.d. 
MM07 Yd4 PpLBZ’ Y+ I+zM330by-d4 
1.6 ( 
2.3 n.d. 1.2 
HBl A(lac) Pz+ Y+ + 20 27 26 
HB2 A(lac) Pz+ Y+ A(l)d(z)Y+ 48 30 26 
HB3 A(lac) Pz+ Y+ A(l)A(Z)Y-d3 : 34 29 48 
71-56-10 A (lac) PZY+ + 14 16 0.6 
71-56-10 pYd3 A(luc) PZY+ A(Mz)Y-d3 - 14 16 0.72 
Strains MM03, MM04, HBY*‘, MMOSY*‘, MM06Yd3 and MM07Yd4 were described in [20]. Strains HBl and 
71-56-10 were constructed by transferring the episomes of BMH611Z+ (A (luc pro) thi/F’fac PZ+Tc pro’) and 
BMH71-56-10 (A (luc pro) thi/F’ PZY pro’), respectively, into strain DP54-1 (A (lac pro) thi strA rif recA. The 
construction of strains HB2, HB3, and 71-56-10 pYd3 has been achieved by transformation of HBl and 71-56-10 with 
plasmids pHB Y+ and pHB Yd3, respectively. The construction of these plasmids is described in [26]. These plasmids 
are unrelated to the &Y-carrying plasmids described in [8]. The Lac phenotype refers to growth on mineral 
salts-lactose plates. The negative-dominant phenotype of the Yd3 mutation is not observable in a F ‘lac PZ+ Y+ 
background (compare strains HB3 and HBl). 100% activity refers to 0.25 pmol . min-’ . mg cell protein-’ for Np,&Gal 
transport (substrate cont. 2 mM), 6 nmol. mitt-’ . mg cell protein-’ for GalSGal transport (substrate cont. 10 FM), and 
15.6 hmol . mitt-’ . mg cell protein-’ for P-galactosidase 
and 71-56-10). In these strains the expected ratio of 
Yd3 to Y’+ gene products is 1.4 and 2.4, respective- 
ly. Within each group, GalSGal is accumulated to 
the same extent. 
4. DISCUSSION 
The &value of the lactose carrier in DodOMalt 
micelles is close to the M, of the polypeptide chain 
(monomer) expected from the DNA sequence of 
the lacy gene. DodOMalt, like other non-ionic 
detergents, is not expected to disrupt 
protein-protein interactions. Indeed, lactose car- 
rier in DodOMalt micelles binds galactoside with a 
1: 1 stoichiometry (J.K. Wright, unpublished). The 
three-dimensional structure of the protein in 
micelles of this detergent must be retained to a 
great extent. Furthermore, the results presented 
here are in agreement with the absence of any co- 
operative effects in substrate binding when the car- 
rier is embedded in the cytoplasmic membrane of 
E. coli [ 131 or after reconstitution [l 11. 
The determination of transport rates in 
lacY+/ T diploid strains failed to confirm the sug- 
gestion [20] that the lactose carrier functions as a 
dimer or higher oligomer. On the other hand, these 
experiments cannot rule out the existence of other 
lacy mutants which might exhibit negative 
dominance with respect to growth and where this 
negative dominance can be verified at the level of 
transport. In the case of an outer membrane pro- 
tein of E. coli, maltoporin, a trimeric structure has 
been confirmed by the analysis of negative- 
dominant mutations [27]. 
The suggestion in [17] that the carrier dimerizes 
only in the presence of an electrochemical proton 
gradient, A,&+, is neither confirmed nor refuted 
by the demonstration that the carrier is a monomer 
in detergent micelles. However, several points 
should be borne in mind: 
14 
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(1) The monomer-dimer hypothesis is presented 
(171 in connection with the change in apparent af- 
finity of the carrier for galactosides in going from 
the active transport mode to the facilitated diffu- 
sion mode. This effect is only observed for some 
substrates (e.g., lactose) but not for others; e.g., 
GalSGal [13]. Both types of substrates are actively 
transported. Therefore, the change in affinity is an 
ancillary effect unrelated to the intrinsic 
mechanism of energy coupling. We had given two 
possible interpretations of this effect within the 
framework of a classical carrier model 1131. 
(2) The transport measurements were conducted 
in the presence of AFH+. Because a negative- 
dominant effect of the Td mutations could not be 
demonstrated by the measurement of transport 
rates, these data do not support a A/&+-dependent 
oligomerization. 
(3) Although the formation of an oligomer from 
parallel-oriented monomers in response to A&+ 
remains possible although, in our view, rather 
unlikely, the existence of subunits oriented anti- 
parallel has been excluded [28]. 
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